Valuation: Medicure Inc.

Market Cap 13.36M 9.41M 8.23M 7.6M 7.09M 889M 13.6M 91.17M 35.39M 439M 35.34M 34.55M 1.53B P/E 2024
-8.8x
P/E 2025 -1.68x
Enterprise Value 10.41M 7.33M 6.42M 5.93M 5.53M 693M 10.6M 71.08M 27.59M 342M 27.55M 26.94M 1.19B EV / Sales 2024
0.13x
EV / Sales 2025 0.31x
Free-Float
72.7%
Yield 2024 *
-
Yield 2025 -
1 day+0.78%
1 week+0.78%
Current month+16.22%
1 month+11.21%
3 months+5.74%
6 months+3.20%
Current year+13.16%
1 week 1.28
Extreme 1.28
1.29
1 month 1
Extreme 1
1.29
Current year 0.85
Extreme 0.85
1.35
1 year 0.85
Extreme 0.85
1.43
3 years 0.63
Extreme 0.63
1.8
5 years 0.63
Extreme 0.63
1.8
10 years 0
Extreme 0
10.67
Manager TitleAgeSince
Chief Executive Officer 79 15/09/1997
Director of Finance/CFO - 01/06/2022
Chief Tech/Sci/R&D Officer - 01/07/2019
Director TitleAgeSince
Chairman 79 15/09/1997
Director/Board Member 92 28/02/2000
Director/Board Member 56 22/01/2013
Date Insider Type Main position Quantity % Market Cap.
06-22Buy

Chief Executive Officer

2,500 0.0240%
06-22Buy

Chief Executive Officer

1,000 0.0096%
06-22Buy

Chief Executive Officer

200 0.0019%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%+0.78%+4.88%+8.40% 9.4M
+3.31%-0.20%+72.71%+128.31% 55.78B
-1.32%+16.55%+89.14%+101.41% 55.66B
-0.73%+3.40%-11.99%-13.18% 23.84B
+2.51%+5.05%+6.63%+408.58% 22.7B
+4.45%+5.06%+36.50%-30.43% 16.12B
+0.24%+6.05%+23.53%+184.90% 13.64B
+5.51%+22.37%+171.85%+333.54% 14.8B
+1.19%+3.89%+76.26%+130.92% 12.16B
-1.80%+7.05%+159.23%+162.57% 11.85B
Average +1.41%+5.54%+62.87%+141.50% 22.66B
Weighted average by Cap. +1.32%+5.02%+66.86%+142.34%

Financials

2024 2025
Net sales 21.91M 15.43M 13.5M 12.46M 11.63M 1.46B 22.3M 150M 58.04M 720M 57.96M 56.66M 2.51B 28.86M 20.32M 17.79M 16.42M 15.31M 1.92B 29.37M 197M 76.45M 948M 76.34M 74.63M 3.3B
Net income -1.04M -732K -640K -591K -551K -69.18M -1.06M -7.09M -2.75M -34.14M -2.75M -2.69M -119M -7.1M -5M -4.37M -4.04M -3.77M -473M -7.22M -48.44M -18.8M -233M -18.78M -18.36M -812M
Net Debt -6.32M -4.45M -3.89M -3.59M -3.35M -421M -6.43M -43.11M -16.74M -208M -16.71M -16.34M -723M -2.94M -2.07M -1.81M -1.68M -1.56M -196M -3M -20.09M -7.8M -96.73M -7.79M -7.61M -337M
Logo Medicure Inc.
Medicure Inc. is a pharmaceutical company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. Its primary focus is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through its United States subsidiary, Medicure Pharma Inc. It operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medications for all Americans, together with customer service and free home delivery. It operates Gateway Medical Pharmacy, located in Portland, Oregon in a medical office building near transportation lines and multiple healthcare clinics and centers. It develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, and compositions containing P5P Analogues.
Employees
38
Date Price Change Volume
30/06/26 CA$1.290 +0.78% 740
24/06/26 CA$1.280 +2.40% 550